RXRA and breast cancer: Amplification of the PPARG gene, and recurrent activating mutations of PPARγ and RXRα that lead to activation of PPARγ/RXRα pathway PPARγ have been linked to a pro-tumorigenic role of PPARγ in luminal-type BC [8–10].